HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jeffrey M Weinberg Selected Research

efalizumab

3/2009Management of moderate to severe plaque psoriasis (part 2): clinical update on T-cell modulators and investigational agents.
2/2009Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents.
7/2007Efalizumab.
5/2006Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab.
9/2005Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept.
1/2005Advances in therapy for psoriasis: an overview of infliximab, etanercept, efalizumab, alefacept, adalimumab, tazarotene, and pimecrolimus.
10/2003An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis.
1/2003Biologic therapy for psoriasis: the T-cell-targeted therapies efalizumab and alefacept.
12/2002Biologic therapy for psoriasis--the first wave: infliximab, etanercept, efalizumab, and alefacept.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jeffrey M Weinberg Research Topics

Disease

24Psoriasis (Pustulosis Palmaris et Plantaris)
07/2015 - 12/2002
7Infection
10/2010 - 01/2002
6Herpes Zoster
01/2008 - 01/2002
5Atopic Dermatitis (Atopic Eczema)
11/2009 - 04/2003
3Psoriatic Arthritis
10/2013 - 04/2008
3Neoplasms (Cancer)
06/2009 - 07/2004
3Basal Cell Carcinoma (Rodent Ulcer)
04/2007 - 05/2002
2Joint Diseases (Joint Disease)
01/2015 - 04/2008
2Skin Diseases
07/2010 - 01/2004
2Exanthema (Rash)
01/2008 - 01/2004
2Pyoderma Gangrenosum
12/2007 - 01/2003
2Wounds and Injuries (Trauma)
07/2005 - 06/2003
2Onychomycosis (Tinea Unguium)
05/2005 - 08/2003
2Pemphigus (Pemphigus Vulgaris)
10/2004 - 08/2003
2Actinic Keratosis
05/2003 - 05/2003
1Nail Diseases (Nail Disease)
01/2015
1Fasciitis (Fascitis)
10/2013
1Tinea Pedis (Athlete's Foot)
10/2011
1Impetigo
10/2010
1Inflammation
07/2010
1Hematologic Neoplasms (Hematological Malignancy)
06/2009
1Skin Neoplasms (Skin Cancer)
06/2009
1Urticaria (Hives)
03/2009
1Breast Neoplasms (Breast Cancer)
01/2008
1Overweight
07/2007
1Herpesviridae Infections (Herpesvirus Infection)
07/2007
1Herpes Genitalis (Genital Herpes)
07/2007
1Herpes Simplex
07/2007
1Herpes Labialis (Fever Blister)
07/2007
1Postherpetic Neuralgia
10/2006
1Acne Vulgaris
04/2006
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2005
1Necrosis
09/2005
1Arthritis (Polyarthritis)
10/2004

Drug/Important Bio-Agent (IBA)

13TNFR-Fc fusion protein (etanercept)FDA Link
01/2015 - 12/2002
9efalizumabFDA Link
03/2009 - 12/2002
8infliximab (Remicade)FDA Link
01/2015 - 12/2002
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2014 - 01/2003
7alefacept (Amevive)FDA Link
03/2009 - 12/2002
5adalimumab (Humira)FDA Link
01/2015 - 01/2005
4imiquimod (Aldara)FDA LinkGeneric
04/2007 - 01/2002
4pimecrolimus (Elidel)FDA Link
01/2005 - 04/2003
3Methotrexate (Mexate)FDA LinkGeneric
01/2015 - 06/2009
3CytokinesIBA
07/2010 - 02/2009
3famciclovir (Famvir)FDA LinkGeneric
07/2007 - 01/2002
3Anti-Bacterial Agents (Antibiotics)IBA
03/2004 - 06/2003
2AcitretinFDA Link
01/2015 - 09/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2015 - 07/2005
2sertaconazoleFDA Link
10/2011 - 02/2009
2Herpes Zoster VaccineIBA
12/2007 - 10/2006
2Periodic AcidIBA
05/2005 - 08/2003
2potassium hydroxideIBA
05/2005 - 08/2003
2tazarotene (Tazorac)FDA Link
01/2005 - 03/2004
2linezolid (Zyvox)FDA Link
03/2004 - 08/2003
2quinupristin-dalfopristin (Synercid)FDA Link
03/2004 - 08/2003
2Fluorouracil (Carac)FDA LinkGeneric
01/2004 - 05/2003
2CollagenIBA
01/2004 - 01/2003
2AutoantibodiesIBA
08/2003 - 07/2003
2Acyclovir (Aciclovir)FDA LinkGeneric
01/2003 - 01/2002
2valacyclovir (valaciclovir)FDA LinkGeneric
01/2003 - 01/2002
1Interleukin-17 (Interleukin 27)IBA
05/2015
1Toll-Like Receptors (Toll-Like Receptor)IBA
05/2015
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2015
1Interleukin-12 (IL 12)IBA
05/2015
1SodiumIBA
01/2015
1golimumabFDA Link
01/2015
1apremilastIBA
01/2015
1monoclonal antibody CNTO 1275 (CNTO 1275)FDA Link
01/2015
1imidazoleIBA
10/2011
1retapamulinFDA Link
10/2010
1FluoroquinolonesIBA
10/2010
1beta-LactamsIBA
10/2010
1Methicillin (Metin)FDA Link
10/2010
1Erythromycin (Erycette)FDA LinkGeneric
10/2010
1pleuromutilinIBA
10/2010
1Mupirocin (Bactroban)FDA LinkGeneric
10/2010
1Interleukin-6 (Interleukin 6)IBA
07/2010
1Interleukin-1 (Interleukin 1)IBA
07/2010
1Interleukin-8 (Interleukin 8)IBA
07/2010
1AN2728IBA
11/2009
1Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2009
1levocetirizineFDA LinkGeneric
03/2009
1AntigensIBA
03/2009
1cyclopamineIBA
09/2006
1GelsIBA
04/2006
1Benzoyl PeroxideFDA LinkGeneric
04/2006
1rituximab (Mabthera)FDA Link
09/2005
1CD20 AntigensIBA
09/2005
1DapsoneFDA Link
07/2005
1OxygenIBA
07/2005
1CosmeticsIBA
07/2004

Therapy/Procedure

10Biological Therapy
06/2009 - 12/2002
3Phototherapy (Light Therapy)
06/2009 - 12/2002
2Off-Label Use
07/2010 - 04/2008
1Therapeutics
07/2015
1Modified Radical Mastectomy (Mastectomy, Modified)
01/2008
1Mammaplasty (Breast Reconstruction)
01/2008
1Drug Therapy (Chemotherapy)
01/2008
1Hyperbaric Oxygenation
12/2007
1Aftercare (After-Treatment)
09/2005